Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1598

1.

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.

Masson S, Latini R, Anand IS, Vago T, Angelici L, Barlera S, Missov ED, Clerico A, Tognoni G, Cohn JN; Val-HeFT Investigators.

Clin Chem. 2006 Aug;52(8):1528-38. Epub 2006 Jun 15.

2.

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.

von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.

J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. Epub 2007 Oct 29.

3.

Pro-B-type natriuretic peptide levels in acute decompensated heart failure.

Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Fitzgerald RL, Maisel AS.

J Am Coll Cardiol. 2008 May 13;51(19):1874-82. doi: 10.1016/j.jacc.2007.12.051.

4.

Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality.

deFilippi CR, Seliger SL, Maynard S, Christenson RH.

Clin Chem. 2007 Aug;53(8):1511-9. Epub 2007 Jun 22.

5.

Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.

Moertl D, Berger R, Struck J, Gleiss A, Hammer A, Morgenthaler NG, Bergmann A, Huelsmann M, Pacher R.

J Am Coll Cardiol. 2009 May 12;53(19):1783-90. doi: 10.1016/j.jacc.2009.01.057.

6.

Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.

Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R.

J Am Coll Cardiol. 2008 Jul 22;52(4):266-72. doi: 10.1016/j.jacc.2008.03.050.

7.

Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.

Richards M, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, Frampton CM, Crozier IG, Yandle TG, Doughty R, MacMahon S, Sharpe N; Christchurch Cardioendocrine Research Group; Australia-New Zealand Heart Failure Group.

J Am Coll Cardiol. 2006 Jan 3;47(1):52-60. Epub 2005 Dec 15.

8.

Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial).

Masson S, Latini R, Anand IS, Barlera S, Angelici L, Vago T, Tognoni G, Cohn JN; Val-HeFT Investigators.

J Am Coll Cardiol. 2008 Sep 16;52(12):997-1003. doi: 10.1016/j.jacc.2008.04.069.

9.

Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure.

Tsutamoto T, Sakai H, Nishiyama K, Tanaka T, Fujii M, Yamamoto T, Horie M.

Circ J. 2007 Dec;71(12):1873-8.

10.

Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.

Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E; PEACE Investigators.

J Am Coll Cardiol. 2007 Jul 17;50(3):205-14. Epub 2007 Jun 29.

11.

Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality.

Christenson RH, Azzazy HM, Duh SH, Maynard S, Seliger SL, Defilippi CR.

Clin Chem. 2010 Apr;56(4):633-41. doi: 10.1373/clinchem.2009.129742. Epub 2010 Feb 18.

12.

N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.

Bruch C, Reinecke H, Stypmann J, Rothenburger M, Schmid C, Breithardt G, Wichter T, Gradaus R.

J Heart Lung Transplant. 2006 Sep;25(9):1135-41. Epub 2006 Aug 2.

PMID:
16962477
13.

Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.

Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.

Am J Cardiol. 2008 Sep 15;102(6):733-7. doi: 10.1016/j.amjcard.2008.04.048. Epub 2008 Jul 9.

PMID:
18773998
14.

Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease.

Mueller T, Gegenhuber A, Poelz W, Haltmayer M.

Clin Chim Acta. 2004 Mar;341(1-2):41-8.

PMID:
14967157
15.

Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure.

Emdin M, Passino C, Prontera C, Fontana M, Poletti R, Gabutti A, Mammini C, Giannoni A, Zyw L, Zucchelli G, Clerico A.

Clin Chem. 2007 Jul;53(7):1289-97. Epub 2007 May 10.

16.

Comparative value of BNP and NT-proBNP in diagnosis of heart failure.

Fonseca C, Sarmento PM, Minez A, Gonçalves E, Covas R, Dias AR, Pina MJ, Ceia F.

Rev Port Cardiol. 2004 Jul-Aug;23(7-8):979-91. English, Portuguese.

17.

Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.

Vanderheyden M, Bartunek, Claeys G, Manoharan G, Beckers JF, Ide L.

Clin Biochem. 2006 Jun;39(6):640-5. Epub 2006 Mar 3.

PMID:
16516185
18.

[Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].

El Mahmoud R, Alibay Y, Brun-Ney D, Boulard JC, Dubourg O, Puy H, Jondeau G.

Arch Mal Coeur Vaiss. 2006 Mar;99(3):201-7. French.

PMID:
16618022
19.

Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.

Lam CS, Burnett JC Jr, Costello-Boerrigter L, Rodeheffer RJ, Redfield MM.

J Am Coll Cardiol. 2007 Mar 20;49(11):1193-202. Epub 2007 Mar 6.

20.

Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure.

Miller WL, Hartman KA, Grill DE, Burnett JC Jr, Jaffe AS.

Clin Chem. 2009 Jan;55(1):78-84. doi: 10.1373/clinchem.2008.108928. Epub 2008 Nov 21.

Supplemental Content

Support Center